A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in mice
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in mice
Authors
Keywords
-
Journal
npj Vaccines
Volume 7, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-07-22
DOI
10.1038/s41541-022-00486-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Introduction of Cysteines in the Stalk Domain of Recombinant Influenza Virus N1 Neuraminidase Enhances Protein Stability and Immunogenicity in Mice
- (2021) Shirin Strohmeier et al. Vaccines
- A Novel Recombinant Influenza Virus Neuraminidase Vaccine Candidate Stabilized by a Measles Virus Phosphoprotein Tetramerization Domain Provides Robust Protection from Virus Challenge in the Mouse Model
- (2021) Shirin Strohmeier et al. mBio
- Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly Protective
- (2020) Anders Madsen et al. IMMUNITY
- Correctly folded - but not necessarily functional - influenza virus neuraminidase is required to induce protective antibody responses in mice
- (2020) Meagan McMahon et al. VACCINE
- Neuraminidase activity and specificity of influenza A virus are influenced by haemagglutinin-receptor binding
- (2019) Jimmy Chun Cheong Lai et al. Emerging Microbes & Infections
- Mucosal Immunity against Neuraminidase Prevents Influenza B Virus Transmission in Guinea Pigs
- (2019) Meagan McMahon et al. mBio
- Pre-existing anti-neuraminidase antibodies are associated with shortened duration of influenza A (H1N1)pdm virus shedding and illness in naturally infected adults
- (2019) Hannah E Maier et al. CLINICAL INFECTIOUS DISEASES
- Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV)
- (2019) Danuta M Skowronski et al. Eurosurveillance
- Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies
- (2018) Yao-Qing Chen et al. CELL
- Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults
- (2018) Sam Jackson et al. VACCINE
- NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
- (2018) Florian Krammer et al. mBio
- Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model
- (2016) Matthew J. Memoli et al. mBio
- Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection
- (2015) Arnold S. Monto et al. JOURNAL OF INFECTIOUS DISEASES
- Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses
- (2015) Wen-Chun Liu et al. JOURNAL OF VIROLOGY
- Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice
- (2015) Teddy John Wohlbold et al. mBio
- H3N2 Mismatch of 2014–15 Northern Hemisphere Influenza Vaccines and Head-to-head Comparison between Human and Ferret Antisera derived Antigenic Maps
- (2015) Hang Xie et al. Scientific Reports
- Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014–2015 Influenza Season
- (2015) Benjamin S. Chambers et al. Cell Reports
- Impact of Influenza B Lineage-Level Mismatch Between Trivalent Seasonal Influenza Vaccines and Circulating Viruses, 1999–2012
- (2014) Terho Heikkinen et al. CLINICAL INFECTIOUS DISEASES
- Antibody Correlates and Predictors of Immunity to Naturally Occurring Influenza in Humans and the Importance of Antibody to the Neuraminidase
- (2013) Robert B. Couch et al. JOURNAL OF INFECTIOUS DISEASES
- Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice
- (2012) Judith D. Easterbrook et al. VIROLOGY
- A Contributing Role for Anti-Neuraminidase Antibodies on Immunity to Pandemic H1N1 2009 Influenza A Virus
- (2011) Glendie Marcelin et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now